Over 300 studies reviewed
Over 20,000 participants since 1990
Over 140 Investigators
Over 130 Postdoctoral Fellowships
The CTN is a Canada-wide partnership of researchers, people living with HIV and their caregivers, governments, health advocates, and the innovative pharmaceutical and biotechnology industry who are all committed to generating knowledge on the prevention, treatment, and management of HIV, hepatitis C (HCV), and other sexually transmitted and blood-borne infections (STBBIs) and developing a cure for HIV, through the conduct of scientifically sound clinical trials, research, and other interventions. The CTN is dedicated to engaging with community and maximizing the impact of research and ultimately improving the health of Canadians by applying knowledge gained through research at home and abroad into clinical and non-clinical practice.
In 2019-2024, the CTN will continue to facilitate and support high-quality, community-collaborative, investigator-driven clinical trials and innovative non-interventional research, while continuing to translate knowledge available in both official languages, to provide mentorship and training, and to share resources and expertise. The CTN’s strategic priorities for 2019-24 are the following:
1. National and Strategic Research Agenda: To develop, adapt and implement a strategic research agenda aligned with current and emerging priorities in HIV, HCV, STBBIs and other related health conditions;
2. Network Structure, Governance and Management: To sustain a national infrastructure that enables Canadian researchers to conduct innovative research in collaboration with the community;
3. Excellence of the Team: To ensure that the CTN continues to be a high-performance, service-oriented, and accountable organization that supports researchers to deliver and translate high-quality science that has a measurable impact on the health of Canadians and beyond;
4. Network Training and Career Development: To continue to strengthen capacity to conduct patient-oriented, clinical and virological, outcomes-based research through training and mentoring initiatives;
5. Network Impact: To ensure the relevance of our work through the active and meaningful involvement of stakeholders and partners (including people living with HIV, community organizations, clinicians, policymakers, and relevant national networks) in CTN activities and governance committees;
6. Knowledge Translation: To continue to enable the timely translation and uptake of knowledge generated through the Network, into health outcome improvements and guidelines for patient care to support the use of best practices by clinicians, community members, and policy makers.
The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.
Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.
We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it
CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation